Growing wound burden
According to the International Diabetes Federation, approximately 537 million adults worldwide were living with diabetes in 2021.
Biomaterial innovation
Advancing Wound Care Through Biomaterial Innovation.
The global burden of acute and chronic wounds continues to grow and remains a significant challenge for healthcare systems worldwide. AKTISCHICHT® develops advanced ECM-mimetic wound care solutions designed for modern wound management and soft tissue repair.
Clinical challenge
Complex wounds require advanced management solutions.
Population aging, increasing rates of diabetes, vascular disease, obesity, trauma injuries, burns, and surgical procedures have contributed to a rising number of patients requiring advanced wound management solutions.
Diabetic foot complications
Approximately 19–34% of individuals with diabetes may develop a diabetic foot ulcer during their lifetime.
Complex wound conditions
Many complex wounds are associated with prolonged inflammation and impaired tissue regeneration.
Research foundation
Regenerative wound technologies engineered through more than a decade of research.
Since 2009, AKTISCHICHT® has focused on advanced biomaterial technologies.
